Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 428-570-1 | CAS number: 187585-64-4
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Toxicity to reproduction
Administrative data
- Endpoint:
- screening for reproductive / developmental toxicity
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2016/2017
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 017
- Report date:
- 2017
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 421 (Reproduction / Developmental Toxicity Screening Test)
- Version / remarks:
- 28 July 2015
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Limit test:
- no
- Justification for study design:
- not applicable for OECD 421
Test material
- Test material form:
- solid: particulate/powder
- Details on test material:
- The stability of the test substance under storage conditions was guaranteed until 24 Apr 2025.
The identity was confirmed by the analytical characterization.
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Wistar
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River Laboratories, Research Models and Services, Germany GmbH
- Females nulliparous and non-pregnant: yes
- Age at study initiation: (P) 11-12 weeks (males) and 10 weeks (females) at receipt
- Weight at study initiation: (P) Males: 348.5 g - 392.2 g; Females: 200.4 g - 234.5 g
- Fasting period before study: no
- Housing: single caging, unless during mating
- Diet: ad libitum
- Water: ad libitum
- Acclimation period: 3 weeks
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 20-24°C
- Humidity (%): 30 - 70%
- Air changes (per hr): 15
- Photoperiod (hrs dark / hrs light): 12/12
IN-LIFE DATES: From: June 2016 To: August 2016
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- corn oil
- Details on exposure:
- PREPARATION OF DOSING SOLUTIONS:
The test material is weighed into calibrated beaker and dopped up with corn oil to achieve the required concentration.
The mixture is intensely mixed with a homogenizer. Before and during administration, the preparations are kept homogenous with a magnetic stirrer.
VEHICLE
- Justification for use and choice of vehicle (if other than water): The substance is not soluble in water.
- Amount of vehicle (if gavage): 4 ml/kg bw - Details on mating procedure:
- - M/F ratio per cage: 1:1
- Length of cohabitation: 14 days or shorter (if proof of mating)
- Proof of pregnancy: sperm in vaginal smear referred to as day 0 of pregnancy
- Further matings after one unsuccessful attempts: no
- After successful mating each pregnant female was caged in individual cages - Analytical verification of doses or concentrations:
- yes
- Details on analytical verification of doses or concentrations:
- The stability of the test substance in corn oil at room temperature over a period of 96 hours had been verified prior to the start of the study.
At the beginning (during premating), twice during gestation and once during lactation of the study each 3 samples were taken from the lowest and highest concentration for potential homogeneity analyses. The 3 samples were withdrawn from the top, middle and bottom of the preparation vessel. These samples were used as a concentration control at the same time. At the above mentioned time points additionally one sample from the mid concentration was taken for concentration control analysis - Duration of treatment / exposure:
- males: 4 weeks
females: 57 days - Frequency of treatment:
- daily (exception: no dosing of animals in labor)
Doses / concentrationsopen allclose all
- Dose / conc.:
- 100 mg/kg bw/day (actual dose received)
- Dose / conc.:
- 300 mg/kg bw/day (actual dose received)
- Dose / conc.:
- 1 000 mg/kg bw/day (actual dose received)
- No. of animals per sex per dose:
- 10
- Control animals:
- yes, concurrent vehicle
- Details on study design:
- - Dose selection rationale: No adverse effects observed at the limit dose in the existing 28-day study (OECD 407).
Anogenital distance (defined as the distance from the anus [center of the anal opening] to the base of the genital tubercle) measurements were conducted in a blind randomized fashion, using a measuring ocular on all live male and female pups on PND 1.
At necropsy on PND 4 and PND 13, the pups were sacrificed with CO2, under isoflurane anesthesia, and examined macroscopically for external and visceral findings. On PND 13 thyroid glands and parathyroid glands were fixed for possible further processing. All surviving male pups were examined for the presence or absence of nipple/areola anlagen on PND 13. The number of nipple/areola anlagen were counted.
Blood samples for hormone measurements were taken from all surplus pups at PND 4 as well as from one male and one female pup per litter at PND 13 during necropsy of pups.
Examinations
- Parental animals: Observations and examinations:
- CAGE SIDE OBSERVATIONS: Yes
- Time schedule: A cageside examination was conducted at least once daily for any signs of morbidity, pertinent behavioral changes and/or signs of overt toxicity.
During the administration period all animals was checked daily for any abnormal clinically signs before the administration as well as within 2 hours and within 5 hours after
the administration. Abnormalities and changes were documented for each animal.
The parturition and lactation behavior of the dams was generally evaluated in the morning in combination with the daily clinical inspection of the dams. Only particular
findings (e.g. inability to deliver or umbilical cord not cut) would be documented on an individual dam basis.
On weekdays (except Saturdays, Sundays and public holidays) the parturition behavior of the dams was inspected in the afternoons in addition to the evaluations in the mornings.
DETAILED CLINICAL OBSERVATIONS: See above
BODY WEIGHT: Yes
- Time schedule for examinations: Once per week. During the mating period, the females were weighed on the day of positive
evidence of sperm (GD 0) and on GD 7, 14 and 20. Females with litter were weighed on the day of parturition (PND 0) and on PND 4, 7, 10 and 13
: - Oestrous cyclicity (parental animals):
- In all parental females in the premating phase, estrous cycle length and normality was evaluated by preparing vaginal smears during a minimum of 2 weeks prior to mating and
throughout cohabitation until there is evidence of sperm in the vaginal smear.
Additionally, on the day of scheduled sacrifice, the estrous status will was determined in all parental female rats.
For all females of the pool estrous cycle normality was valuated before the beginning of the administration period (The estrous cycle data of these individuals are reported and can be found in the raw data). - Sperm parameters (parental animals):
- Parameters examined in all Pmale parental generations:
testis weight, epididymis weight, special attention was given on the stages of spermatogenesis in the testes during histopathology. - Litter observations:
- STANDARDISATION OF LITTERS
- Performed on day 4 postpartum: yes
- If yes, maximum of 8 pups/litter (4/sex/litter as nearly as possible); excess pups were killed and discarded.
PARAMETERS EXAMINED
The following parameters were examined in F1 offspring:
number and sex of pups, stillbirths, live births, postnatal mortality, presence of gross anomalies, weight gain, physical or behavioural abnormalities, anogenital distance (AGD), presence of nipples/areolae in male pups]
GROSS EXAMINATION OF DEAD PUPS:
yes, for external and internal abnormalities.
If applicable and possible, cause of death for pups that died prematurely was determined.
Other: On PND 4, as a result of standardization, the surplus pups, were sacrificed under isoflurane anesthesia by decapitation. Blood was sampled for determination of thyroid
hormone concentrations
On PND 13, one selected male and one female pup per litter were sacrificed under isoflurane anesthesia by decapitation. Blood was sampled for determination of thyroid
hormone concentrations. Thyroid glands/parathyroid glands were fixed in neutral buffered 4% formaldehyde solution. - Postmortem examinations (parental animals):
- SACRIFICE
- Male animals: All surviving animals after 28 days
- Maternal animals: All surviving animals at the end of postnatal day 13
GROSS NECROPSY
- Gross necropsy consisted of external and internal examinations including the cervical, thoracic, and abdominal viscera.
HISTOPATHOLOGY / ORGAN WEIGHTS
The tissues indicated below were prepared for microscopic examination and weighed, respectively.
Organ weight determination:
1. Anesthetized animals
2. Epididymides
3. Ovaries
4. Prostate
5. Seminal vesicles with coagulating glands
6. Testes
7. Thyroid glands (fixed)
8. Uterus (with cervix)
Organs for microscopic examination:
1. All gross lesions
2. Cervix
3. Coagulating glands
4. Epididymides (modified Davidson's solution)
5. Ovaries (modified Davidson's solution)
6. Oviducts
7. Prostate
8. Seminal vesicles
9. Testes (modified Davidson's solution)
10. Thyroid glands
11. Vagina
12. Uterus - Postmortem examinations (offspring):
- GROSS NECROPSY
- Gross necropsy consisted of external and internal examinations including the cervical, thoracic, and abdominal viscera.
HISTOPATHOLOGY / ORGAN WEIGTHS
No histopathology and organ weight examination was performed for offspring. - Statistics:
- Included, statistical test depending on parameter
- Reproductive indices:
- Mating indices, fertility indices, gestation index
- Offspring viability indices:
- viability index, survival index
Results and discussion
Results: P0 (first parental generation)
General toxicity (P0)
- Clinical signs:
- no effects observed
- Mortality:
- mortality observed, non-treatment-related
- Body weight and weight changes:
- no effects observed
- Organ weight findings including organ / body weight ratios:
- no effects observed
Reproductive function / performance (P0)
- Reproductive function: oestrous cycle:
- no effects observed
- Reproductive function: sperm measures:
- no effects observed
- Reproductive performance:
- no effects observed
Details on results (P0)
Remark: High-dose male No. 37 and female No. 137 are not used for the calculation of the fertility parameters, as the male animal No. 37 was found dead on mating day 1.
Subsequently high-dose female No. 137 had no sperm in vaginal smear (no GD 0) and consequently no implants or pups.
The mean duration until sperm was detected (GD 0) varied between 2.2 and 2.4 days without any relation to dosing.
All female rats delivered pups or had implants in utero with the following exceptions:
• Control female No. 105 (mated with male No. 5) did not become pregnant.
• High-dose female No. 138 (mated with male No. 38) did not become pregnant.
The fertility index varied between 100% in test groups 1 and 2, 90% in test group 0 and 88.9% in test group 3. These values reflect the normal range of biological variation inherent in the strain of rats used for this study.
The mean duration of gestation was similar in all test groups: 22.2 days in test groups 1 and 3, 22.3 days in test group 0 and 22.4 days in test group 2.
The gestation index varied between 90% (test group 2) and 100% (test groups 0, 1 and 3).
One female animal (No. 125; 300 mg/kg bw/d) had all pups stillborn (complete litter loss on PND 0) and was found dead on PND 2. The death of this animal is considered as a spontaneous finding which cannot be attributed to the test substance administration.
Implantation was not affected by the treatment since the mean number of implantation sites was comparable between all test substance-treated groups and the control, taking normal biological variation into account (13.1 / 11.0 / 13.0 and 13.5 implants/dam in test groups 0-3, respectively).
Effect levels (P0)
- Dose descriptor:
- NOAEL
- Effect level:
- >= 1 000 mg/kg bw/day (actual dose received)
- Based on:
- test mat.
- Sex:
- male/female
- Basis for effect level:
- other: No effects observed at the limit dose
Target system / organ toxicity (P0)
- Critical effects observed:
- no
Results: F1 generation
General toxicity (F1)
- Clinical signs:
- no effects observed
- Mortality / viability:
- no mortality observed
- Body weight and weight changes:
- no effects observed
- Gross pathological findings:
- no effects observed
Details on results (F1)
The rate of liveborn pups was also not affected by the test substance, as indicated by live birth indices of 99.1% / 98.9% / 89.1% and 100% in test groups 0-3.
The mean number of delivered F1 pups per dam and the rates of liveborn F1 pups were evenly distributed among the test groups. The respective values reflect the normal range of biological variation inherent in the strain used in this study.
The number of stillborn pups as well as perinatal loss in test group 2 was increased (without attaining statistical significance). This finding is incidental and mainly caused by one litter (No. 125) who has all pups stillborn and died thereafter.
The viability index indicating pup mortality during early lactation (PND 0-4) varied between 97.1% (test group 1), 97.2% (test group 2), 98.2% (test group 3) and 99.3% (control) without
relation to dosing. The survival index indicating pup mortality PND 4-13 was 100% in all test groups.
One male runt was seen in the control, two male and two female runts were seen in test group 1 and one female runt was seen in test group 3.
Neither on anogenital distance nor anogenital index test substance-related effects were noted in all treated F1 offspring (100, 300 and 1000 mg/kg bw/d]).
The slightly but statistically significantly increased anogenital index of female pups in test group 2 (300 mg/kg bw/d) is considered as spontaneous in nature due to the lack of doseresponse relationship.
The number of low-, mid- and high-dose male pups having areolae was not influenced by the test substance when examined on PND 13.
The percentage of male pups in test groups 1-3 having areolae was not influenced by the test substance when examined on PND 13.
Effect levels (F1)
- Dose descriptor:
- NOAEL
- Generation:
- F1
- Effect level:
- >= 1 000 mg/kg bw/day (actual dose received)
- Based on:
- test mat.
- Sex:
- male/female
- Basis for effect level:
- other: no adverse effects at the limit dose
- Remarks on result:
- other: F1 raised until PND 21
Target system / organ toxicity (F1)
- Critical effects observed:
- no
Overall reproductive toxicity
- Reproductive effects observed:
- no
Any other information on results incl. tables
Analyses confirmed the overall accuracy of the prepared concentrations and the homogeneity of the test substance in the vehicle. The stability of these preparations was also demonstrated over a period of 96 hours under ambient conditions.
During the mating and post-mating period in some high dosed male animals salivation after treatment was seen. From the temporary, short appearance immediately after dosing it is likely, that this finding was induced by a bad taste of the test substance or local affection of the upper digestive tract. This finding was not considered to be an adverse and toxicologically relevant effect.
Applicant's summary and conclusion
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
Although ECHA is providing a lot of online material in your language, part of this page is only in English. More about ECHA’s multilingual practice.
Welcome to the ECHA website. This site is not fully supported in Internet Explorer 7 (and earlier versions). Please upgrade your Internet Explorer to a newer version.
the-echa-website-uses-cookies
find-out-more-on how-we-use-cookies